Product Information
AUROVELA 21 1.5-30 TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3427 per EA under NDC 65862093574. Its NADAC has been published 373 times since Jul 3, 2019.
FDA first approved this application on Jun 26, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30; 1.5 ug/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862093574
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ETHINYL ESTRADIOL; NORETHINDRONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA207581FDA Approved
6/26/2017
TE Code
AB
On Market Since
6/26/2017
Price Statistics
The NADAC for AUROVELA 21 1.5-30 TABLET has been published 373 times since Jul 3, 2019, and over the history we have for it it has declined 47.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3427 per EA |
|---|---|
| All-time high | $0.6934 (Aug 14, 2019) |
| All-time low | $0.3066 (Jul 17, 2024) |
| 52-week high | $0.3923 |
| 52-week low | $0.3344 |
| Median price | $0.5261 |
| Average price | $0.5001 |
| Largest weekly change | +67.3% (Aug 21, 2024) |
| Weeks tracked | 373 |
| Tracking since | Jul 3, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AUROVELA 21 1.5-30 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AUROVELA 21 1.5-30 TABLET, manufactured by Aurobindo Pharma Limited, is $0.3427 per EA (NDC 65862093574), effective Aug 19, 2026.
How has the price of AUROVELA 21 1.5-30 TABLET changed over time?
Over the history we have for it, the NADAC for AUROVELA 21 1.5-30 TABLET has declined 47.9%. It has been tracked across 373 weekly CMS publications since Jul 3, 2019.
What are the highest and lowest recorded NADAC prices for AUROVELA 21 1.5-30 TABLET?
Since Jul 3, 2019, the NADAC for AUROVELA 21 1.5-30 TABLET has ranged from a low of $0.3066 (Jul 17, 2024) to a high of $0.6934 (Aug 14, 2019), with a median of $0.5261 per EA.
Are there cheaper alternatives to AUROVELA 21 1.5-30 TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AUROVELA 21 1.5-30 TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures AUROVELA 21 1.5-30 TABLET?
AUROVELA 21 1.5-30 TABLET (NDC 65862093574) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.